带来 发表于 2025-3-23 10:42:59

Submitted on: 15 April 2014.
Revised on: 29 July 2014.
Accepted on: 29 August 2014.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Germinate 发表于 2025-3-23 17:02:12

Submitted on: 07 May 1999.
Revised on: 22 August 1999.
Accepted on: 26 September 1999.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

证实 发表于 2025-3-23 18:17:18

http://reply.papertrans.cn/1/84/8346/8346-13.png

效果 发表于 2025-3-24 00:55:42

Submitted on: 11 August 2007.
Revised on: 20 November 2007.
Accepted on: 03 January 2008.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

打包 发表于 2025-3-24 06:07:06

Submitted on: 07 July 2022.
Revised on: 30 September 2022.
Accepted on: 31 October 2022.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Commentary 发表于 2025-3-24 06:52:44

http://reply.papertrans.cn/1/84/8346/8346-16.png

BIDE 发表于 2025-3-24 14:27:58

http://reply.papertrans.cn/1/84/8346/8346-17.png

半导体 发表于 2025-3-24 18:35:33

http://reply.papertrans.cn/1/84/8346/8346-18.png

Receive 发表于 2025-3-24 22:47:40

http://reply.papertrans.cn/1/84/8346/8346-19.png

催眠药 发表于 2025-3-25 03:03:35

Submitted on: 23 October 2024.
Revised on: 18 January 2025.
Accepted on: 02 March 2025.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: 1 [2] 3 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (ENDOC